Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to add sessions to your schedule and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
Stiina Aarum
European Medicines Agency, Netherlands
Senior Scientific Specialist, Scientific Advice, Product Development...
MA
Mark Abdoo
FDA, United States
Associate Commissioner for Global Policy and Strategy
Ciby Abraham
AstraZeneca, United States
Senior Director and Group Manager, Project and Product Leadership
Maria Paula Bautista Acelas
DIA, United States
Senior Scientific Project Manager
Yvonne Adu-Boahen
Food and Drugs Authority, Ghana
Head of Clinical Trials Department
MA
Michael Ageboh
Pharmalex / Cencora, United States
Senior Manager, MedTech Services
Meha Ahmed
U.S. Food and Drug Administration, United States
ORISE Research Fellow
ZA
Zinah Alabdulkarim
SFDA, Saudi Arabia
Senior Scientific Evaluation Expert
Abdulaziz Alageel
Saudi Food and Drug Authority, Saudi Arabia
Alert and Monitoring Expert
Donia Albastaki
Ministry of Health, State of Kuwait, Kuwait
Acting Director, Pharmaceutical and Herbal Medicine Registration...
Rita Algorri
Amgen, United States
Associate Director, Global Regulatory Affairs (CMC)
Jeff Allen
Friends of Cancer Research, United States
President and Chief Executive Officer
Saeed Alshahrani
Saudi Food & Drug Authority, Saudi Arabia
Alarm & Control Expert
Maria Amaya
Genentech, A Member of the Roche Group, United States
Lead External Advocacy, North America
Vasanti Anand
BMS, United States
Regulatory Writer
Hillary Andrews
Friends of Cancer Research, United States
Director, Regulatory and Research Partnerships
Artem Andrianov
Cyntegrity Germany GmbH, Germany
CEO
Maria Apostolaros
PhRMA, United States
Deputy Vice President, Science and Regulatory Advocacy
Barbara Isquith Arone
IQVIA, United States
Vice President, Evidence Generation for Medical Affairs
AA
Alex Asiimwe
Gilead, United Kingdom
Head of RWE Generation & Partnerships
Troy Astorino
PicnicHealth, United States
CTO
Susanne Ausborn
Roche, Switzerland
Global Head International Regulatory Policy
Kassa Ayalew
FDA, United States
Director, DCCE, OSI, Office of Compliance, CDER
NA
Nicolai Ayasse
Critical Path Institute, United States
Clinical Outcome Assessment Scientist
MB
Maria Baier
Boehringer Ingelheim, Germany
Data Scientist
Rosalyn Bailey
Syneos Health, United States
Executive Director NA & LATAM Head – Global Regulatory Affairs...
Junaid Bajwa
Pioneering Intelligence, United Kingdom
Senior Partner, Head of UK, and Science Partner, Pioneering...
DB
Denyse Baker
Eli Lilly and Company, United States
Assoc. Vice President Global Quality Compliance
Venkatraman Balasubramanian
VB Insights, LLC, United States
Healthcare and Life Sciences Strategic Advisor
Greg Ball
ASAPprocess, United States
Safety Data Scientist
Simge Baloglu
Bluerock Therapeutics, United States
SVP Analytical and Quality Control
Khaudeja Bano
Genentech, United States
Vice President, Combination Product Quality
SB
Szczepan Baran
Chief Barks and Purrs Officer, United States
Tech4Pets
LB
Leo Barella
Takeda, United States
Chief Technology Officer
Brian Barnes
BioNTech, United States
Director, Risk Management Strategy, Global Clinical Development...
Shelly Barnes
UCB Biosciences, United States
Global Clinical Innovations Lead
Tajuana Barron
PCM Trials, United States
Vice President Project Management Global Clinical Trials
Sean Barry
Health Products Regulatory Authority (HPRA), Ireland
Senior Pharmaceutical Assessor
Andrew Bate
GlaxoSmithKline, United Kingdom
Vice President, Head of Safety Innovation and Analytics
AB
Ashley Bates
Syneos Health, United States
Anna-Marika Bauer
Critical Path Institute, United States
Regulatory Specialist
JB
Julian Beach
MHRA, United Kingdom
Interim Executive Director of Healthcare Quality and Access (HQA)
Maree Beare
Clinials, Australia
Founder and CEO
Emmanuel Belabe
ArisGlobal, United States
Global Head, Operational Excellence • Global Customer Excellence
Rachel Belani-Barker
Syneos Health, United States
Sr Account Development Mgr
AB
Andrea Bell-Vlasov
U.S. Food & Drug Administration, United States
Science Policy Analyst
Simon Bennett
Biogen, United Kingdom
Director, EU Regulatory Policy
Robyn Bent
FDA, United States
Director, Patient Focused Drug Development, OCD, CDER
Stephane Berard
Health Canada, Canada
Interim Supervisor-Health Product Compliance East Unit
Cedric Berger
F. Hoffmann-La Roche, Switzerland
Head of Knowledge Extraction and Integration
Cedric Berger
F. Hoffmann-La Roche, Switzerland
Head of Knowledge Extraction and Integration
Janis Bernat
IFPMA, Switzerland
Director, Scientific and Regulatory Affairs
Scott Berry
Berry Consultants LLC, United States
President and Senior Statistical Scientist
Amy Bertha
Bayer, United States
Executive Director, Regulatory Policy and Science
James Bertram
FDA, United States
Director, Office of Combination Products, OC
JB
James Best
GSK, United Kingdom
Digital Transformation Lead (Medical Writing)
AB
Anish Bhatnagar
Soleno Therapeutics Inc, United States
Chief Executive Officer
Alex Bliu
Health Canada, Canada
Senior Biostatistician
Katie Bloom
Ultragenyx, United States
Executive Director, Co-Head of PMO, Program Management Office
William Blumentals
Sanofi, United States
Head of Pharmacoepidemiology, Specialty Care
Anna Bode
Kearney, Germany
Principal
Thomas Bognanno
Alliance Practice, United States
Patient Representative
Paul Bolot
Bayer Consumer Care AG, Switzerland
Global Regulatory Strategist
David Borasky
WCG Clinical, United States
Vice President, IRB Compliance
MB
Marcin Boruk
Health Canada, Canada
acting Director, Business Facilitation and Modernization Directorate,...
Jaclyn Bosco
IQVIA, United States
Vice President & General Manager, Global Head of Epidemiology...
Amanda Kirby Bowles
Deloitte, United States
Managing Director
Donna Boyce
Pfizer Inc, United States
Head and Senior Vice President of Global Regulatory Sciences
Brian Bradbury
Amgen, United States
Vice President, Center for Observational Research
MB
Marie Bradley
FDA, United States
Senior Advisor, Real-World Evidence Analytics, Office of Medical...
Chris Bray
Merck Serono Ltd., United Kingdom
Head of Global Regulatory Affairs Precision Medicine & Companion...
Tywnia Brewton
Astellas , United States
Executive Director, Human Resources
Denise Bronner
Empactful Ventures, United States
Founder & CEO
Philip (P.J.) Brooks
National Center for Advancing Translational Sciences (NCATS), NIH, United States
Deputy Director, Division of Rare Diseases Research Innovation
Nathan Brown
Akin Gump Strauss Hauer & Feld LLP, United States
Partner
Nick Brown
Certara, United States
Director, Global Portfolio Leader, Certara.AI
Sharon Brown-Singleton
MedNorth Health Center, United States
Chief Strategy Officer
James Browning
Amgen, United States
Director of Biostatistical Programming, Center for Observational...
Mandy Budwal-Jagait
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GCP
Kevin Bugin
Amgen, United States
Head of Global Regulatory Policy and Intelligence
Magda Bujar
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Associate Director, Regulatory Programme and Strategic Partnerships
Huwaida Bulhan
Roche Kenya Limited, Kenya
Senior Clinical Research Operations Lead Area Africa
Namandjé Bumpus
Bumpus Advising, United States
Founding Principal
TB
Teresa Buracchio
FDA, United States
Director, Office of Neuroscience, OND, CDER
Mehmet Burcu
Merck & Co., Inc., United States
Senior Director, Epidemiology
JB
John Burke
Microsoft, United States
Cybersecurity Sales Director
David Campard
Novo Nordisk A/S, Denmark
CMC RA Specialist
Ulka Campbell
Aetion Inc, United States
Head of Scientific Strategy
Eleanor Caplan
Johnson & Johnson Innovative Medicine, United States
Senior Principal Scientist
Emily Carter
AbbVie, United States
Director, Data Science & Analytics
Jason Casavant
Synterex, Inc., United States
Executive Director, Medical Writing
Alison Cave
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
June Cha
Milken Institute, United States
Policy Director, FasterCures
Meghana Chalasani
FDA, United States
Associate Director for Clinical Trial Innovation, Office of New...
James Chambers
Tufts Medical Center, United States
Professor, Institute for Clinical Research and Health Policy Studies
Joan Chambers
Tufts Center For the Study of Drug Development, United States
Independent Senior Consultant
Chimwemwe Chamdimba
African Union Development Agency-NEPAD, South Africa
African Medicines Regulation Harmonization Programme Head
Ankush Chandna
ZS Associates , United States
Data Science Lead, Research and Development Excellence
Andrew Chang
Novo Nordisk, United States
Vice President, Quality and Regulatory Compliance
SC
Shou-Bai Chao
CanSino Biologics Inc., China
Chief Operating Officer
Maryann Chapin
Food and Drug Administration, United States
ORISE Fellow
Arnaub Chatterjee
Datavant, United States
President & GM - Life Sciences
Sharon Chen
AlphaLife Sciences, United States
Founder and CEO
Xianwen Chen
University of Macau, Macao
Student
Xiaoyuan Chen
Tsinghua University, China
Professor
Matthew Chervenak
Allsci, United States
Founder & CEO
JC
Joan Cheung
NNIT, United States
Senior Consultant
Isabel Chicharo
European Medicines Agency, Netherlands
Head of Regulatory Data Management
Karla Childers
Johnson & Johnson, United States
Head, Bioethics-Based Science and Technology Policy
Constance Chisha
University of the Witwatersrand, South Africa
PhD Student
Stephanie Choi
EMD Serono, United States
Director, US Global Regulatory and Scientific Policy (GRASP)
Susan Chong
Amgen Inc., United States
Senior Manager, Global Regulatory Policy and Intelligence
DS
Dhruv Sunil Choudhary
University of Westminster, United Kingdom
Student
AC
Ashar Choudhry
Bristol Myers Squibb, United States
Executive Director, Enterprise Program Leadership & Operational...
Andrew Ciupek
GO2 for Lung Cancer, United States
Associate Director, Clinical Research
R. Angelo De Claro
FDA, United States
Associate Director for Global Clinical Sciences, Oncology Center of...
JC
James Cobbs
Apath Nexus Consulting, United States
Founder and Principal
Thos Cochrane
Harvard Medical School, United States
Director, Fellowships in Bioethics
Cal Collins
OpenClinica, LLC, United States
Chief Technology Officer
Vivian Combs
Eli Lilly and Company, United States
Director of Scientific Communications
Pamela Concepcion
Astrazeneca, United States
Patient Safety Scientist
BC
Bill Cook
AstraZeneca, United States
Senior Global Medical Affairs Leader
Donna Libretti Cooke
ImpactSphere Clinical, LLC, United States
Chief Impact Officer & Owner
Emer Cooke
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Torrey Cope
Sidley Austin LLP, United States
Partner
Jhon Cores
Moderna, Inc, United States
Associate Director, Medical Writing
AC
Ana Corona
University of Utah, United States
Translator
Karen Correa
Boehringer Ingelheim, United States
Vice President, Clinical Development Operations
Solange Corriol-Rohou
AstraZeneca , France
Senior Director, Global Regulatory Affairs & Policy, R&D,...
Solange Corriol-Rohou
AstraZeneca , France
Senior Director, Global Regulatory Affairs & Policy, R&D,...
Stephen Corson
Phastar, United Kingdom
Associate Director, Statistics and Technical Solutions
Catherine Coulouvrat
Sanofi, France
Head of Health Value Translation
Alysha Croker
Health Canada, Canada
Director of the Centre for Policy, Pediatrics and International...
Matthew Curin
Galderma, United States
Sr. Dir, Head of Program Management, Therapeutic Dermatology
Kavita Dada
FDA, United States
Associate Director for Regulatory Operations, OSI, OC, CDER
Gregory Daniel
Eli Lilly and Company, United States
Global Head of Public Policy, Global Corporate Affairs
AT
Akilah T Daniels-Vincent
Microsoft Cloud Marketing - Industry, United States
Sr. Product Marketing Manager
SD
Saurabh Das
Tata Consultancy Services Ltd, India
Associate Consultant
Patricia Davidson
Tufts Center for the Study of Drug Development, United States
PALADIN Consortium Director
Dedric Day
Eli Lilly and Company, United States
Senior Director- Strategic Talent Partnerships
Kimberly Dayato
Mount St Mary's University, United States
Full Time Student
Pallabi De
Synterex, Inc., United States
Senior Director, Medical Writing Technology and Content Architecture
Suranjan De
FDA, United States
Deputy Director, Regulatory Science, OSE, CDER
Andrew Deavin
GSK, Belgium
Senior Director, Regulatory Affairs
Chris Decker
United States
President and CEO
Sarah Demmon
Eli Lilly, United States
Vice President
Jenny Denney
Parexel , United States
EVP, Global Head Parexel FSP
CD
Camille DeSantis
Edelman, United States
Managing Director, US Lead Health Brand Development
SD
Sai Dharmarajan
Sarepta Therapeutics, United States
Director, Biostatistics
Victoria DiBiaso
France
Global Head, Patient Informed Development and Health Value Translation
Robert DiCicco
TransCelerate Biopharma Inc., United States
Vice President, Portfolio Management
Abigail Dirks
Tufts Center for the Study of Drug Development, United States
Data Scientist
JD
Julia Djonova
Swissmedic, Switzerland
Head Division ATMP
Pamela Dobay
Biogen, Switzerland
Director
Bridget Doherty
Johnson & Johnson Innovative Medicine, United States
Director, Access and Policy Research
Victoria Dohnal
Johnson & Johnson, United States
Director, Global Regulatory Policy and Intelligence
Amanda Donovan
Takeda, United States
Director, Emerging Priorities & Innovation
SD
Sahith Doppalapudi
Bristol-Myers Squibb Company, United States
Associate Director, PV Analytics Analytics Center of Excellence
CD
Carolyn Dorgan
Sutton's Creek, United States
Director, Technical Service
Brian Doyle
Moderna, United States
Senior Director, Technical Development
Megan Doyle
Eli Lilly & Company, United States
Associate Vice President, Assistant General Counsel - Diagnostics
Nancy Dreyer
Dreyer Strategies LLC, United States
Founder
RD
Ran Duan
Vertex Pharmaceuticals, United States
Director Biometrics
Kelly Dumais
Clario, United States
Director, eCOA Science and Consulting
KD
Katie Duncan
GSK, United States
Director, CMC Policy and Advocacy
Joseph Dustin
eClinical Consulting, United States
Founder and Managing Partner
Joseph Dustin
Dauntless Eclinical Strategies, United States
Founder and Principal
Roshan D'Souza
Roche Products Limited, United Kingdom
Head of Quality Excellence Digital, PDQ
Danielle Friend Economo
Johnson & Johnson Innovative Medicine, United States
Senior Director, US Head Regulatory Policy and Intelligence
Jason Eisfelder
Bayer, United States
DSO Practitioner
Tamei Elliott
DIA, United States
Director, Global Scientific Content
NE
Noel Ellison
Trialwise, Inc., United States
Director of Biostatistics
KE
Khaled El Emam
University of Ottawa, Canada
Professor
Jennifer Emerson
Boehringer Ingelheim, Germany
Head Quality Analytics & Risk Management
Scott Evans
George Washington University Milken Institute of Public Health, United States
Professor and Founding Chair, Department of Biostatistics and...
Sarah Fairfield
AbbVie, United States
Associate Director, RA Device and Combination Products
Tala Fakhouri
FDA, United States
Associate Director for Data Science and Artificial Intelligence, CDER
Tony Fantana
Eli Lilly, United States
Sr. Dir
Jennifer Farmer
Friedreich's Ataxia Research Alliance (FARA), United States
Chief Executive Officer
Marwan Fathallah
DIA, United States
President & Chief Executive Officer
Jessica Federer
Angelini Ventures, United States
Board Member
Yuli Felistia
National Brain Center, Mahar Mardjono Hospital, Indonesia
Head of Clinical Research Unit, Research Manager
RF
Ryan Ferguson
VA Boston Healthcare System, United States
Acting Director, Cooperative Studies Program
Andrea Ferris
LUNGevity Foundation, United States
President and CEO
Jay Ferro
Clario, United States
EVP & Chief Information and Technology Officer
Lawrence Fine
Lawrence Fine, LLC, United States
Business Consultant
Tetyana Fine
Astrazeneca, United States
Director, Global Regulatory Affairs
Kelly Fitzgerald
WCG , United States
Executive IRB Chair and Vice President of IBC Affairs
Ron Fitzmartin
Decision Analytics, United States
Principal Consultant
Ron Fitzmartin
FDA, United States
Senior Advisor, Office of Regulatory Operations, CBER
Ruby Ford
Tufts School of Medicine, United States
Research Analyst
Jeffrey Francer
Eli Lilly and Company, United States
Vice President, Head of Global Regulatory Policy & Strategy
Julie Frearson
Charles River Laboratories, United States
Senior Vice President, Chief Scientific Officer
Motoki Fujii
EPS Group, Japan
Senior Professional
Yasuhiro Fujiwara
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
HF
Hina Fukuta
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Denise Fulton
Regulatory Affairs Professionals Society (RAPS), United States
Vice President, Research & Content Strategy
Michele Fusaroli
Uppsala Monitoring Centre, Sweden
Juan Garcia-Burgos
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
CG
Carlos Garner
Eli Lilly and Company, United States
Vice-President Global Regulatory Affairs
1
2
3
4
Share Modal
Share this link via
Or copy link
Copy
